Cargando…
R‐High‐CHOP/CHASER/LEED with autologous stem cell transplantation in newly diagnosed mantle cell lymphoma: JCOG0406 STUDY
Although induction immunochemotherapy including high‐dose cytarabine and rituximab followed by high‐dose chemotherapy (HDC) with autologous stem cell transplantation (ASCT) is recommended for younger patients (≤65 years old) with untreated mantle cell lymphoma (MCL), no standard induction and HDC re...
Autores principales: | Ogura, Michinori, Yamamoto, Kazuhito, Morishima, Yasuo, Wakabayashi, Masashi, Tobinai, Kensei, Ando, Kiyoshi, Uike, Naokuni, Kurosawa, Mitsutoshi, Gomyo, Hiroshi, Taniwaki, Masafumi, Nosaka, Kisato, Tsukamoto, Norifumi, Shimoyama, Tatsu, Fukuhara, Noriko, Yakushijin, Yoshihiro, Ohnishi, Kazunori, Miyazaki, Kana, Sawada, Kenichi, Takayama, Nobuyuki, Hanamura, Ichiro, Nagai, Hirokazu, Kobayashi, Hirofumi, Usuki, Kensuke, Kobayashi, Naoki, Ohyashiki, Kazuma, Utsumi, Takahiko, Kumagai, Kyoya, Maruyama, Dai, Ohmachi, Ken, Matsuno, Yoshihiro, Nakamura, Shigeo, Hotta, Tomomitsu, Tsukasaki, Kunihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6125440/ https://www.ncbi.nlm.nih.gov/pubmed/29957865 http://dx.doi.org/10.1111/cas.13719 |
Ejemplares similares
-
Long‐term follow‐up after R‐High CHOP/CHASER/LEED with Auto‐PBSCT in untreated mantle cell lymphoma—Final analysis of JCOG0406
por: Ogura, Michinori, et al.
Publicado: (2023) -
R‐CHOP‐14 versus R‐CHOP‐14/CHASER for upfront autologous transplantation in diffuse large B‐cell lymphoma: JCOG0908 study
por: Kagami, Yoshitoyo, et al.
Publicado: (2020) -
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1)
por: Nakamura, Nobuhiko, et al.
Publicado: (2021) -
Promising results of an anti-CCR4 antibody, KW-0761, for relapsed Adult T-Cell Leukemia-Lymphoma (ATL)
por: Utsunomiya, Atae, et al.
Publicado: (2011) -
HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1)
por: Ri, Masaki, et al.
Publicado: (2021)